Observational Study of Advanced and Metastatic Melanoma Patients in Spain

What this Trial Is About

Researchers are conducting an observational, multicenter study to collect and analyze medical information from patients diagnosed with advanced metastatic or unresectable melanoma. The study focuses on understanding the characteristics of these patients at their first diagnosis, either as initial metastatic or unresectable disease or as the first metastatic relapse after previous treatment for localized melanoma. This research aims to provide important insights into melanoma progression and treatment patterns in Spain. The study observes patients receiving usual clinical care without assigning any specific treatment or intervention. Treatment decisions are made independently by the patients healthcare providers as part of routine medical practice. Patients included have been diagnosed with stage III, metastatic, or unresectable melanoma since January 8, 2018, and their medical records will be reviewed to gather relevant data. Participants involvement primarily involves the collection of information from their medical records, with no additional diagnostic or follow-up procedures beyond standard care. Researchers will review baseline sample characteristics to understand patient profiles at diagnosis. The study does not involve any direct intervention or changes to treatment and focuses on long-term data collection to support melanoma research and patient care improvements.

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain